Brief: Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results
Nov 25 (Reuters) - Anavex Life Sciences Corp AVXL.O: ANAVEX LIFE SCIENCES REPORTS FISCAL 2025 FOURTH QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE ANAVEX LIFE SCIENCES CORP QTRLY EPS $-0.11 ANAVEX LIFE SCIENCES CORP: ANTICIPATES AT ITS CURRENT CASH UTILIZATION RATE, APPROXIMATE CASH RUNWAY OF MORE THAN 3 YEARS Source text: ID:nGNX35yMHk Further company coverage: AVXL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anavex Life Sciences
See all newsBrief: Anavex Provides Corporate Update, Announces Completion Of Clinical Conduct Of Adme And Ddi Clinical Studies
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board